CUTANEOUS HYPERPIGMENTATION CAUSED BY SYSTEMIC DRUGS
- 1 July 1992
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 31 (7) , 458-466
- https://doi.org/10.1111/j.1365-4362.1992.tb02689.x
Abstract
No abstract availableThis publication has 90 references indexed in Scilit:
- Imipramine hyperpigmentation: A slate-gray discoloration caused by long-term imipramine administrationPublished by Elsevier ,1991
- Pigmented postacne osteoma cutis in a patient treated with minocycline: Report and review of the literatureJournal of the American Academy of Dermatology, 1991
- Minocycline hydrochloride hyperpigmentation complicating treatment of venous ectasia of the extremitiesJournal of the American Academy of Dermatology, 1991
- Skin pigmentation from clofazimine therapy in leprosy patients: A reappraisalJournal of the American Academy of Dermatology, 1990
- Acanthosis nigricans: A cutaneous marker of tissue resistance to insulinJournal of the American Academy of Dermatology, 1989
- Cutaneous ultrastructural changes and photosensitivity associated with amiodarone therapyJournal of the American Academy of Dermatology, 1987
- Exogenous ochronosis resulting from quinine injectionsJournal of the American Academy of Dermatology, 1986
- Nail changes secondary to systemic drugs or ingestantsJournal of the American Academy of Dermatology, 1984
- Drug- and heavy metal-induced hyperpigmentationJournal of the American Academy of Dermatology, 1981
- AntimalarialsJournal of the American Academy of Dermatology, 1981